Page not found

• 
• 
• 
• 

Search results

1. COVID-19 antibody ‘cocktail’ discovered at VUMC protects chronically ill

   ... developed by AstraZeneca reduced the risk of symptoms in a study of immunocompromised and chronically ill adults later exposed to the ... methods  for discovering highly potent antiviral human monoclonal antibodies and validating their ability to protect small ...

   sommers - 08/23/2021 - 9:57am

2. Robot prototype shows promise for microsurgery on eyes and aneurysms

   ... For a sense of scale, an inch contains 25,400 microns. A human red blood cell is about eight microns wide, the same size as some ... and significantly smaller than the width of the average human hair. “Our design achieves motion resolutions of 1 micron or less ...

   sommers - 11/22/2019 - 11:16am

3. Vanderbilt receives $20 million from The William K. Warren Foundation to further treatments for brain disorders

   ... various cognitive diseases. It recently went into human phase-1 FDA clinical trials—a unique accomplishment for an academic ... designed to encourage mentorship and the development of a long-term pipeline of research leaders. “Genuine breakthroughs sometimes ...

   sommers - 05/06/2020 - 12:38pm

4. CN Bio Innovations, a Vanderbilt licensee, and FDA sign collaborative agreement using Organ-on-Chip technologies

   ... the use of the devices to provide precise data about how human cells and organs interact with new drugs, and their ability to accurately predict the success of drugs prior to human clinical trials. ...

   costess - 02/21/2019 - 9:51am

5. Therapeutic Antibody Discovery and Development Event

   ... on several dozen patents covering immunoglobulin transgenic mice and therapeutic antibodies. He received his Ph.D. in Molecular and ...

   sommers - 02/21/2019 - 9:51am

6. Partnership to help bring Zika virus therapy to clinic

   ... Cambridge, England, for development of high-yield, antibody-expressing cell lines. Initially Batavia will deploy the system to produce ... is using a proprietary platform to discover and develop human antibodies for the treatment and prevention of infectious diseases. ...

   sommers - 09/20/2019 - 2:07pm

7. VUMC and IDBiologics Ally in Race to Develop Breakthrough Medicines for COVID-19

   ... to partner with IDBiologics to race potent neutralizing human monoclonal antibodies to the clinic,” Dr. Crowe said. “The speed with ... is a biotech startup focused on the development of human monoclonal antibodies (mAbs) for the treatment and prevention of major ...

   sommers - 05/28/2020 - 2:55pm

8. VUMC chikungunya antibody set to enter clinical trial

   ... which has been delivered in a Phase I safety trial in human subjects. The goal is for cells that take up the encapsulated RNA to then ... and powerful way to combat the virus, Crowe said, “because human beings make the most amazing antibodies.” Article courtesy of ...

   sommers - 02/27/2019 - 2:41pm

9. Vanderbilt-Ancora Request for Proposals

   ... studies designed to qualify a candidate to enter into human clinical trials. Once IND-enabling studies are completed, the research ... for the collaboration are limited to novel therapeutics for human diseases (small molecules and biologics) and associated enabling ...

   mullerg - 08/06/2018 - 11:30am

10. Vanderbilt University anti-inflammatory therapy licensed to Amytrx is now in clinical trials for eczema treatment

    ... co-founder of Amytrx, Hawiger will be involved in further study and research on this transformative anti-inflammatory therapy by conducting preclinical studies in experimental models of human disease with high unmet need.   “The progression of this work ...

    sommers - 10/30/2020 - 12:45pm